This study is framed to evaluate the effect of medicated enema (Rasnadi Basti) in the patients of multiple joints pain disease Vatarakta (Gouty Arthritis)

Phase 3

• Conditions: Health Condition 1: M109- Gout, unspecifiedHealth Condition 2: M958- Other specified acquired deformities of musculoskeletal system

• Registration Number: CTRI/2022/07/043915
• Lead Sponsor: Shri Krishna Government Ayurvedic College and Hospital kurukshetra

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 August 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Sujects with clinical features of Vatarakta.

2.Subjects with chronicity of disease more than 6 months and less than 2 years.

3.Subjects of either sex between age group of 30-60 years.

The paitents fit for Basti karma.

5.Subject with uric acid level above 6mg/dl for females and 7mg/dl for males.

Exclusion Criteria

1.Subject with clinical features other than Vatarakta.

2.Subjects with chronicity of disease less than 6 months and above 2 years.

3.Subjects of either sex below 30 years and above 2 years.

4.The paitents unfit for Basti karma.

5.Subjects with uric acid above 9mg/dl.

6.All connective tissue disorders other than Gouty Arthritis.

7.Systemic Lupus Erythematous and other auto immune disorders.

8.Paitents having systemic pathologies like cardiac disease, renal disease and hypertension.

9.Subjects with uncontrolled diabetes, systemic disorders and endocrine disorders.

10.Paitents having tuberculosis of spine,spinal tumors, vertebral fractures, surgical conditions and pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The outcome will be assessed on the basis of objective parameters like Sandhi Shoola (Joint pain), Sandhi Shotha (Joint swelling), Sparsh Asahatvam (Tenderness), Daha (Burning sensation), Raaga (Erythema), Twak Vaivarnya (Discoloration), Stabdhata (Stiffness), Toda (Piercing sensation.Timepoint: At baseline, 11th day, 30th day and 60th day

Secondary Outcome Measures

Name	Time	Method
The outcome will be assessed on the basis of objective parameters like Range of movement, VAS scale- for pain assessment, CBC, ESR, CRP, Serum uric acid, Urine Examination at an interval of 11th, 30th, 60th days. <br/ ><br> <br/ ><br>Timepoint: At baseline, 11th day, 30th day and 60th day